Curto Marcello, Cole Banumathi K, Lallemand Dominique, Liu Ching-Hui, McClatchey Andrea I
MGH Center for Cancer Research, Harvard Medical School Department of Pathology, Charlestown, MA 02129, USA.
J Cell Biol. 2007 Jun 4;177(5):893-903. doi: 10.1083/jcb.200703010.
The neurofibromatosis type 2 (NF2) tumor suppressor, Merlin, is a membrane/cytoskeleton-associated protein that mediates contact-dependent inhibition of proliferation. Here we show that upon cell-cell contact Merlin coordinates the processes of adherens junction stabilization and negative regulation of epidermal growth factor receptor (EGFR) signaling by restraining the EGFR into a membrane compartment from which it can neither signal nor be internalized. In confluent Nf2(-/-) cells, EGFR activation persists, driving continued proliferation that is halted by specific EGFR inhibitors. These studies define a new mechanism of tumor suppression, provide mechanistic insight into the poorly understood phenomenon of contact-dependent inhibition of proliferation, and suggest a therapeutic strategy for NF2-mutant tumors.
2型神经纤维瘤病(NF2)的肿瘤抑制因子默林是一种与膜/细胞骨架相关的蛋白质,可介导接触依赖性增殖抑制。我们在此表明,细胞间接触时,默林通过将表皮生长因子受体(EGFR)限制在一个既不能发出信号也不能内化的膜区室中,来协调黏附连接稳定过程和EGFR信号的负调控。在汇合的Nf2(-/-)细胞中,EGFR激活持续存在,驱动持续增殖,而这种增殖可被特异性EGFR抑制剂阻断。这些研究定义了一种新的肿瘤抑制机制,为人们了解甚少的接触依赖性增殖抑制现象提供了机制性见解,并为NF2突变型肿瘤提出了一种治疗策略。